{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Corilagin", "NF-\u03baB", "PI3K/AKT", "RANKL", "osteoclast"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32681612", "DateCompleted": {"Year": "2021", "Month": "05", "Day": "07"}, "DateRevised": {"Year": "2021", "Month": "05", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "07", "Day": "18"}], "Language": ["eng"], "ELocationID": ["10.1111/jcmm.15657"], "Journal": {"ISSN": "1582-4934", "JournalIssue": {"Volume": "24", "Issue": "18", "PubDate": {"Year": "2020", "Month": "Sep"}}, "Title": "Journal of cellular and molecular medicine", "ISOAbbreviation": "J Cell Mol Med"}, "ArticleTitle": "Corilagin suppresses RANKL-induced osteoclastogenesis and inhibits oestrogen deficiency-induced bone loss via the NF-\u03baB and PI3K/AKT signalling pathways.", "Pagination": {"StartPage": "10444", "EndPage": "10457", "MedlinePgn": "10444-10457"}, "Abstract": {"AbstractText": ["Over-activated osteoclastogenesis, which is initiated by inflammation, has been implicated in osteoporosis. Corilagin, a natural compound extracted from various medicinal herbaceous plants, such as Cinnamomum cassia, has antioxidant and anti-inflammatory activities. We found that Corilagin suppressed osteoclast differentiation in a dose-dependent manner, significantly decreased osteoclast-related gene expression and impaired bone resorption by osteoclasts. Moreover, phosphorylation of members of the nuclear factor-kappaB (NF-\u03baB) and PI3K/AKT signalling pathways was reduced by Corilagin. In a murine model of osteoporosis, Corilagin inhibited osteoclast functions in vivo and restored oestrogen deficiency-induced bone loss. In conclusion, our findings suggested that Corilagin inhibited osteoclastogenesis by down-regulating the NF-\u03baB and PI3K/AKT signalling pathways, thus showing its potential possibility for the treatment of osteoporosis."], "CopyrightInformation": "\u00a9 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopedic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}, {"Identifier": [], "Affiliation": "Orthopedics Research Institute of Zhejiang University, Hangzhou, China."}], "LastName": "Lu", "ForeName": "Jinwei", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopedic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}, {"Identifier": [], "Affiliation": "Orthopedics Research Institute of Zhejiang University, Hangzhou, China."}], "LastName": "Ye", "ForeName": "Chenyi", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopedic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}, {"Identifier": [], "Affiliation": "Orthopedics Research Institute of Zhejiang University, Hangzhou, China."}, {"Identifier": [], "Affiliation": "Department of Orthopedic Surgery, The First People's Hospital of Xiaoshan District, Hangzhou, China."}], "LastName": "Huang", "ForeName": "Yanyong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopedic Surgery, Hangzhou Third Hospital, Hangzhou, China."}], "LastName": "Huang", "ForeName": "Donghui", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopedic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}, {"Identifier": [], "Affiliation": "Orthopedics Research Institute of Zhejiang University, Hangzhou, China."}], "LastName": "Tang", "ForeName": "Lan", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopedic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}, {"Identifier": [], "Affiliation": "Orthopedics Research Institute of Zhejiang University, Hangzhou, China."}], "LastName": "Hou", "ForeName": "Weiduo", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopedic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}, {"Identifier": [], "Affiliation": "Orthopedics Research Institute of Zhejiang University, Hangzhou, China."}], "LastName": "Kuang", "ForeName": "Zhihui", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopedic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}, {"Identifier": [], "Affiliation": "Orthopedics Research Institute of Zhejiang University, Hangzhou, China."}], "LastName": "Chen", "ForeName": "Yazhou", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopedic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}, {"Identifier": [], "Affiliation": "Orthopedics Research Institute of Zhejiang University, Hangzhou, China."}], "LastName": "Xiao", "ForeName": "Shining", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Orthopedics Department, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China."}], "LastName": "Yishake", "ForeName": "Mumingjiang", "Initials": "M"}, {"Identifier": ["0000-0002-5937-3878"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopedic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}, {"Identifier": [], "Affiliation": "Orthopedics Research Institute of Zhejiang University, Hangzhou, China."}], "LastName": "He", "ForeName": "Rongxin", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Cell Mol Med", "NlmUniqueID": "101083777", "ISSNLinking": "1582-1838"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Actins"}, {"RegistryNumber": "0", "NameOfSubstance": "Estrogens"}, {"RegistryNumber": "0", "NameOfSubstance": "Glucosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Hydrolyzable Tannins"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "NFATC Transcription Factors"}, {"RegistryNumber": "0", "NameOfSubstance": "Osteoprotegerin"}, {"RegistryNumber": "0", "NameOfSubstance": "RANK Ligand"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "62LOS9TW6D", "NameOfSubstance": "corilagin"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Actins"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Bone Marrow Cells"}, {"QualifierName": ["pathology"], "DescriptorName": "Bone Resorption"}, {"QualifierName": ["drug effects"], "DescriptorName": "Down-Regulation"}, {"QualifierName": ["deficiency"], "DescriptorName": "Estrogens"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Glucosides"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Hydrolyzable Tannins"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["metabolism"], "DescriptorName": "NFATC Transcription Factors"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Osteoclasts"}, {"QualifierName": ["drug effects"], "DescriptorName": "Osteogenesis"}, {"QualifierName": ["metabolism"], "DescriptorName": "Osteoprotegerin"}, {"QualifierName": [], "DescriptorName": "Ovariectomy"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phosphatidylinositol 3-Kinases"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": ["pharmacology"], "DescriptorName": "RANK Ligand"}, {"QualifierName": [], "DescriptorName": "RAW 264.7 Cells"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "RNA, Messenger"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Yang J, Li J, Cui X, et al. Blocking glucocorticoid signaling in osteoblasts and osteocytes prevents mechanical unloading\u2010induced cortical bone loss. Bone. 2020;130:115108.", "ArticleIdList": ["31704341"]}, {"Citation": "Kwak SC, Baek JM, Lee CH, Yoon KH, Lee MS, Kim JY. Umbelliferone prevents lipopolysaccharide\u2010induced bone loss and suppresses RANKL\u2010induced osteoclastogenesis by attenuating Akt\u2010c\u2010Fos\u2010NFATc1 signaling. Int J Biol Sci. 2019;15(11):2427\u20102437.", "ArticleIdList": ["PMC6775311", "31595160"]}, {"Citation": "Ardura JA, Rackov G, Izquierdo E, Alonso V, Gortazar AR, Escribese MM. Targeting macrophages: friends or foes in disease? Front Pharmacol. 2019;10:1255.", "ArticleIdList": ["PMC6819424", "31708781"]}, {"Citation": "Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337\u2010342.", "ArticleIdList": ["12748652"]}, {"Citation": "Stevens JA, Rudd RA. The impact of decreasing U.S. hip fracture rates on future hip fracture estimates. Osteoporos Int. 2013;24(10):2725\u20102728.", "ArticleIdList": ["PMC4717482", "23632827"]}, {"Citation": "Hu B, Sun X, Yang Y, et al. Tomatidine suppresses osteoclastogenesis and mitigates estrogen deficiency\u2010induced bone mass loss by modulating TRAF6\u2010mediated signaling. FASEB J. 2019;33(2):2574\u20102586.", "ArticleIdList": ["30285579"]}, {"Citation": "Zhou CH, Shi ZL, Meng JH, et al. Sophocarpine attenuates wear particle\u2010induced implant loosening by inhibiting osteoclastogenesis and bone resorption via suppression of the NF\u2010kappaB signalling pathway in a rat model. Br J Pharmacol. 2018;175(6):859\u2010876.", "ArticleIdList": ["PMC5825302", "29130485"]}, {"Citation": "Shen BO, Yu J, Wang S, et al. Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo. Hepatology. 2008;47(2):473\u2010483.", "ArticleIdList": ["18157836"]}, {"Citation": "Komori T. Animal models for osteoporosis. Eur J Pharmacol. 2015;759:287\u2010294.", "ArticleIdList": ["25814262"]}, {"Citation": "Miller PD. Management of severe osteoporosis. Expert Opin Pharmacother. 2016;17(4):473\u2010488.", "ArticleIdList": ["26605922"]}, {"Citation": "Wagner EF, Matsuo K. Signalling in osteoclasts and the role of Fos/AP1 proteins. Ann Rheum Dis. 2003;62(90002):83ii\u201085.", "ArticleIdList": ["PMC1766737", "14532157"]}, {"Citation": "Cummings SR, Lui LY, Eastell R, Allen IE. Association between drug treatments for patients with osteoporosis and overall mortality rates: a meta\u2010analysis. JAMA Intern Med. 2019;179(11):1491.", "ArticleIdList": ["PMC6704731", "31424486"]}, {"Citation": "Vijayaraghavalu S, Gao Y, Rahman MT, et al. Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis. Biomaterials. 2020;227:119558.", "ArticleIdList": ["PMC6870877", "31654872"]}, {"Citation": "Chiu YH, Ritchlin CT. DC\u2010STAMP: a key regulator in osteoclast differentiation. J Cell Physiol. 2016;231(11):2402\u20102407.", "ArticleIdList": ["PMC4946985", "27018136"]}, {"Citation": "Rho TW, Lee SY, Han SY, et al. Glycyrrhizae radix inhibits osteoclast differentiation by inhibiting c\u2010Fos\u2010dependent NFATc1 expression. Am J Chin Med. 2017;45(2):283\u2010298.", "ArticleIdList": ["28231743"]}, {"Citation": "An Y, Zhang H, Wang C, et al. Activation of ROS/MAPKs/NF\u2010kappaB/NLRP3 and inhibition of efferocytosis in osteoclast\u2010mediated diabetic osteoporosis. FASEB J. 2019;33(11):12515\u201012527.", "ArticleIdList": ["PMC6902677", "31461386"]}, {"Citation": "Lee BS. Myosins in osteoclast formation and function. Biomolecules. 2018;8(4):157.", "ArticleIdList": ["PMC6317158", "30467281"]}, {"Citation": "Anesi A, Generali L, Sandoni L, Pozzi S, Grande A. From osteoclast differentiation to osteonecrosis of the jaw: molecular and clinical insights. Int J Mol Sci. 2019;20(19):4925.", "ArticleIdList": ["PMC6801843", "31590328"]}, {"Citation": "Zhou J, Zhang C, Sun Y, et al. Corilagin attenuates allergy and anaphylactic reaction by inhibiting degranulation of mast cells. Med Sci Monit. 2018;24:891\u2010896.", "ArticleIdList": ["PMC5819305", "29434182"]}, {"Citation": "Li L\u2010J, Zhang S\u2010J, Liu P, et al. Corilagin Interferes With Toll\u2010Like Receptor 3\u2010Mediated Immune Response In Herpes Simplex Encephalitis. Front Mol Neurosci. 2019;12:83.", "ArticleIdList": ["PMC6497770", "31080403"]}, {"Citation": "Nandini HS, Naik PR. Action of corilagin on hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin\u2010induced diabetic rats. Chem Biol Interact. 2019;299:186\u2010193.", "ArticleIdList": ["30582900"]}, {"Citation": "Zhou X, Xiong J, Lu S, et al. Inhibitory effect of corilagin on miR\u201021\u2010regulated hepatic fibrosis signaling pathway. Am J Chin Med. 2019;47(7):1541\u20101569.", "ArticleIdList": ["31752524"]}, {"Citation": "Ding YI, Ren D, Xu H, et al. Antioxidant and pro\u2010angiogenic effects of corilagin in rat cerebral ischemia via Nrf2 activation. Oncotarget. 2017;8(70):114816\u2010114828.", "ArticleIdList": ["PMC5777734", "29383122"]}, {"Citation": "Yeo S\u2010G, Song JH, Hong E\u2010H, et al. Antiviral effects of Phyllanthus urinaria containing corilagin against human enterovirus 71 and Coxsackievirus A16 in vitro. Arch Pharm Res. 2015;38(2):193\u2010202.", "ArticleIdList": ["24752860"]}, {"Citation": "Klein\u2010J\u00fanior L, da Silva L, Boeing T, et al. The protective potential of phyllanthus niruri and corilagin on gastric lesions induced in rodents by different harmful agents. Planta Med. 2017;83(1\u201302):30\u201039.", "ArticleIdList": ["27220075"]}, {"Citation": "Yanbing D, Lixia H, Jun C, Song H, Fahu Y, Jinwen T. Corilagin attenuates the parkinsonism in japanese encephalitis virus induced parkinsonism. Transl Neurosci. 2018;9:13\u201016.", "ArticleIdList": ["PMC6057262", "30042861"]}, {"Citation": "Deng Y, Li X, Li X, et al. Corilagin induces the apoptosis of hepatocellular carcinoma cells through the mitochondrial apoptotic and death receptor pathways. Oncol Rep. 2018;39(6):2545\u20102552.", "ArticleIdList": ["PMC5983927", "29693193"]}, {"Citation": "Gambari R, Hau DK, Wong WY, Chui CH. Sensitization of Hep3B hepatoma cells to cisplatin and doxorubicin by corilagin. Phytother Res. 2014;28(5):781\u2010783.", "ArticleIdList": ["23913631"]}, {"Citation": "Ming Y, Zheng Z, Chen L, et al. Corilagin inhibits hepatocellular carcinoma cell proliferation by inducing G2/M phase arrest. Cell Biol Int. 2013;37(10):1046\u20101054.", "ArticleIdList": ["23686743"]}, {"Citation": "Jia L, Jin H, Zhou J, et al. A potential anti\u2010tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF\u2010beta signaling pathways. BMC Complement Altern Med. 2013;13:33.", "ArticleIdList": ["PMC3598193", "23410205"]}, {"Citation": "Jia L, Zhou J, Zhao H, et al. Corilagin sensitizes epithelial ovarian cancer to chemotherapy by inhibiting Snail glycolysis pathways. Oncol Rep. 2017;38(4):2464\u20102470.", "ArticleIdList": ["28791374"]}, {"Citation": "Attar R, Cincin ZB, Bireller ES, Cakmakoglu B. Apoptotic and genomic effects of corilagin on SKOV3 ovarian cancer cell line. Onco Targets Ther. 2017;10:1941\u20101946.", "ArticleIdList": ["PMC5384738", "28408846"]}, {"Citation": "Yokota K. Inflammation and osteoclasts. Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(5):367\u2010376.", "ArticleIdList": ["29238019"]}, {"Citation": "Tanaka Y, Nakayamada S, Okada Y. Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr Drug Targets Inflamm Allergy. 2005;4(3):325\u2010328.", "ArticleIdList": ["16101541"]}, {"Citation": "Zhi X, Wang L, Chen H, et al. l\u2010tetrahydropalmatine suppresses osteoclastogenesis in vivo and in vitro via blocking RANK\u2010TRAF6 interactions and inhibiting NF\u2010kappaB and MAPK pathways. J Cell Mol Med. 2020;24(1):785\u2010798.", "ArticleIdList": ["PMC6933417", "31725199"]}, {"Citation": "Gallagher JC, Sai AJ. Molecular biology of bone remodeling: implications for new therapeutic targets for osteoporosis. Maturitas. 2010;65(4):301\u2010307.", "ArticleIdList": ["PMC2834801", "20116187"]}, {"Citation": "LaCroix AZ, Cauley JA, Pettinger M, et al. Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women's Health Initiative Observational Study. Ann Intern Med. 2003;139(2):97\u2010104.", "ArticleIdList": ["12859159"]}, {"Citation": "Reddy BU, Mullick R, Kumar A, et al. A natural small molecule inhibitor corilagin blocks HCV replication and modulates oxidative stress to reduce liver damage. Antiviral Res. 2018;150:47\u201059.", "ArticleIdList": ["29224736"]}, {"Citation": "Li X, Deng Y, Zheng Z, et al. Corilagin, a promising medicinal herbal agent. Biomed Pharmacother. 2018;99:43\u201050.", "ArticleIdList": ["29324311"]}, {"Citation": "Guo S, Fu Y, Xiong S, Lv J. Corilagin protects the acute lung injury by ameliorating the apoptosis pathway. Biomed Pharmacother. 2017;95:1743\u20101748.", "ArticleIdList": ["28962079"]}, {"Citation": "Liu FC, Chaudry IH, Yu HP. Hepatoprotective effects of corilagin following hemorrhagic shock are through Akt\u2010dependent pathway. Shock. 2017;47(3):346\u2010351.", "ArticleIdList": ["PMC5293163", "27559697"]}, {"Citation": "Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther. 2007;9(Suppl 1):S1.", "ArticleIdList": ["PMC1924516", "17634140"]}, {"Citation": "Chen X, Zhi X, Wang J, Su J. RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation. Bone Res. 2018;6:34.", "ArticleIdList": ["PMC6255918", "30510839"]}, {"Citation": "Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys. 2008;473(2):139\u2010146.", "ArticleIdList": ["PMC2413418", "18395508"]}, {"Citation": "Chen L, Wei XQ, Evans B, Jiang W, Aeschlimann D. IL\u201023 promotes osteoclast formation by up\u2010regulation of receptor activator of NF\u2010kappaB (RANK) expression in myeloid precursor cells. Eur J Immunol. 2008;38(10):2845\u20102854.", "ArticleIdList": ["18958885"]}, {"Citation": "Liao HJ, Tsai HF, Wu CS, Chyuan IT, Hsu PN. TRAIL inhibits RANK signaling and suppresses osteoclast activation via inhibiting lipid raft assembly and TRAF6 recruitment. Cell Death Dis. 2019;10(2):77.", "ArticleIdList": ["PMC6349873", "30692521"]}, {"Citation": "Chen X, Zhi X, Pan P, et al. Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL\u2010induced osteoclastogenesis. FASEB J. 2017;31(11):4855\u20104865.", "ArticleIdList": ["PMC5636701", "28739641"]}, {"Citation": "Sang C, Zhang J, Zhang Y, Chen F, Cao X, Guo L. TNF\u2010alpha promotes osteoclastogenesis through JNK signaling\u2010dependent induction of Semaphorin3D expression in estrogen\u2010deficiency induced osteoporosis. J Cell Physiol. 2017;232(12):3396\u20103408.", "ArticleIdList": ["28059444"]}, {"Citation": "Xin Z, Jin C, Chao L, et al. A matrine derivative M54 suppresses osteoclastogenesis and prevents ovariectomy\u2010induced bone loss by targeting ribosomal protein S5. Front Pharmacol. 2018;9:22.", "ArticleIdList": ["PMC5797611", "29441015"]}, {"Citation": "Chen X, Zhi X, Cao L, et al. Matrine derivate MASM uncovers a novel function for ribosomal protein S5 in osteoclastogenesis and postmenopausal osteoporosis. Cell Death Dis. 2017;8(9):e3037.", "ArticleIdList": ["PMC5636967", "28880271"]}, {"Citation": "Wagner EF. Functions of AP1 (Fos/Jun) in bone development. Ann Rheum Dis. 2002;61(Supplement 2):40ii\u201042.", "ArticleIdList": ["PMC1766713", "12379619"]}]}], "History": [{"Year": "2019", "Month": "12", "Day": "12"}, {"Year": "2020", "Month": "6", "Day": "24"}, {"Year": "2020", "Month": "6", "Day": "29"}, {"Year": "2020", "Month": "7", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32681612", "PMC7521306", "10.1111/jcmm.15657"]}}]}